维生素D受体基因启动子Fok Ⅰ多态性与尿钙浓度的关系

目的 研究维生素D受体(VDR)基冈启动子Fok Ⅰ多态性与尿钙浓度之间的关系.方法 应用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)对50例泌尿系结石(结石组)及50例非泌尿系结石患者(对照组)的外周血进行Fok I多态性检测,分析两组间基因型和等位基因的频率分布,并用常规尿生化分析仪比较两组的24 h尿钙浓度.结果 结石组基因型分布:FF 28%(14/50),Ff 52%(26/50),ff 20%(10/50);对照组:FF 34%(17/50),Ff 56%(28/50),ff10%(5/50),其中FF和ff基因型分布在两组中差异有统计学意义(P<0.05).结石组与对照组等位基因F分布频率分别为54%(54/100)和62%(62/100)(P>O.05);f分别为46%(461100)和38%(381100)(P<0.05).结石组FF、Ff、ff基因型的24 h尿钙浓度分别为(0.030±0.008)mmol/kg、(0.037±0.009)mmol/kg和(0.081±0.013)mmol/kg,对照组分别为(0.028±0.006)mmol/kg、(0.036±0.002)mmol/kg和(0.043+0.003)mmol/kg,FF和Ff基因型在两组中尿钙浓度之间差异没有统计学意义(P>0.05),而ff基因型差异有统计学意义(P<0.05).结论 VDR基因起始密码子中Fok I多态性与泌尿系结石患者尿钙浓度升高有关系.     

维生素D受体基因启动子Fok I多态性与尿钙浓度的关系

目的 研究维生素D受体（VDR）基冈启动子Fok Ⅰ多态性与尿钙浓度之间的关系.方法 应用聚合酶链反应-限制性片段长度多态性（PCR-RFLP）对50例泌尿系结石（结石组）及50例非泌尿系结石患者（对照组）的外周血进行Fok I多态性检测,分析两组间基因型和等位基因的频率分布,并用常规尿生化分析仪比较两组的24 h尿钙浓度.结果 结石组基因型分布：FF 28%（14/50）,Ff 52%（26/50）,ff 20%（10/50）;对照组：FF 34%（17/50）,Ff 56%（28/50）,ff10%（5/50）,其中FF和ff基因型分布在两组中差异有统计学意义（P〈0.05）.结石组与对照组等位基因F分布频率分别为54%（54/100）和62%（62/100）（P〉O.05）;f分别为46%（461100）和38%（381100）（P〈0.05）.结石组FF、Ff、ff基因型的24 h尿钙浓度分别为（0.030±0.008）mmol/kg、（0.037±0.009）mmol/kg和（0.081±0.013）mmol/kg,对照组分别为（0.028±0.006）mmol/kg、（0.036±0.002）mmol/kg和（0.043＋0.003）mmol/kg,FF和Ff基因型在两组中尿钙浓度之间差异没有统计学意义（P〉0.05）,而ff基因型差异有统计学意义（P〈0.05）.结论 VDR基因起始密码子中Fok I多态性与泌尿系结石患者尿钙浓度升高有关系.     

下腔静脉人工血管置换术后放疗对血管内膜的影响

Objective To investigate the effects of postoperative irradiation on the neointima of artificial blood vessel after prosthetic vessel replacement of inferior vena cava in dogs.Methods Sixteen dogs underwent ePTFE (expended poly-tetra fluoroethylene) prosthetic vessel replacement of inferior vena cava and were then randomly divided into radiotherapy group and control group (n=8 each).For the radiotherapy group, external radiation (35 Gy) was given at two weeks after surgery.Samples were then collected from these two groups on week 8 for study of patency rate of the artificial blood vessel.In addition,HE staining, measurement of neointima thickness, PCNA (proliferating cell nuclear antigen) and CD34 stained immunohistochemistry were performed, and number of endothelial cells (ECs) within 100 Jim neointima were counted.Results The patency rate was 100% (8/8) in radiotherapy group and 75% (6/8)in control group on week 8.The neointima thickness at each segment of artificial blood vessel was significantly decreased in radiotherapy group compared with those in the control group [proximal segment:(610.69±32.90)μm vs(753.39±10.36)μm; mid segment: (530.51 ±32.14 )jun vs(636.55?0.23)μm; distal segment: (544.52±41.99)μm vs (710.39±30.92)μm, all P＜0.01].The percentage counts of PCNA positive cells in each segment of artificial blood vessel were lowered in the radiotherapy group compared with those in the control group [proximal segment: (45.1±7.5)% vs(56.3±7.8)% ; mid segment: (29.2 ±±4.1)% vs(36.6±4.9)%; distal segment: (33.8±5.5)% vs (40.76±.7)%, all P＜0.05].There was no statistical difference in number of ECs within 100 p,m neointima between two groups (P>0.05).Conclusion External radiation (35 Gy) after prosthetic vessel replacement of inferior vena cava has no significant impact on the patency of artificial blood vessel, nor on linings of vascular smooth muscle cells in neointima, but may inhibit the neointima proliferation and PCNA expression.     

小于胎龄儿大鼠胰岛素抵抗与ghrelin水平的关系

Objective To observe the change of insulin sensitivity index (ISI) and ghrelin level, to examine their correlation and to explore the role and significance of ghrelin in insulin resistance (IR) in small for gestational age (SGA) rats. Methods The SGA models were established by starvation method in pregnant SD rats. Experimental rats were grouped by body length and/or body weight 4 weeks after birth.Experiment grouping: ( 1 )SGA group with growth catch-up (Group S 1, n=26 ); (2)SGA group without growth catch-up (Group S2, n=31 ); (3)Normal control group was composed by male rats whose mothers ate and drank freely during pregnancy (Group C, n=27). Body weight and serum ghrelin level was checked 4 weeks after birth. Body weight, serum ghrelin, fasting blood glucose and fasting insulin were tested when the rats were 12 weeks old, and then ISI was calculated. Correlation of all the indexes was analyzed. Results The ISI of 12-week-old SGA rats was significantly decreased as compared to normal control (Group S1:2.00± 0.58, Group S2:2.23±0.58 vs Group C: 3.17±0.54, both P＜0.05). Serum ghrelin level of SGA rats was decreased compared with Group C, but the disparity was not statistically significant [Group S1: (1.357± 0.548) μg/L, Group S2: (1.428±0.714) μg/L vs Group C: (1.843±0.459) μg/L,both P＞0.05 ]. Ghrelin level in 12-week-old rats presented negative correlation with fasting insulin level in blood(r=-0.836,P＜0.01 ), and positive correlation with ISI (r=0.810, P＜0.01). Conclusion The decrease of serum ghrelin level is correlated with IR in adult SGA rats. Low serum level of ghrelin may be the result of IR.     

丙泊酚镇静下瑞芬太尼抑制喉罩置管和气管插管心血管反应的半数有效浓度比较

Objective To measure the medium effective concentration (EC50) of remifentanil for blunting cardiovascular response to placement of LMA-Fastrach, LMA-Proseal and tracheal intubation, and to compare the change of brain bispectral index (BIS) during these procedures. Methods Sixty-three patients (ASA I-II) scheduled for cholecystectomy under general anesthesia were enrolled. According to different options of intubation, all the patients were randomly allocated into three groups (n=21 each): group T by laryngoscope and tracheal intubation, group F by LMA-Fastrach and group P by LMA-Proseal.Initially, a target plasma concentration of 4 mg/L propofol was chosen, and was adjusted to maintain BIS between 45 and 55. Then, the effect-site concentration of remifentanil was started at designed concentration according to Minto's pharmacokinetic model. Five minutes later, 0.6 mg/kg (2 ED95) rocuronium was given, and intubation was performed 2 min after rocuronium administration. The pre- and post-induction mean arterial pressure (MAP), heart rate (HR) and BIS were compared among these groups. MAP and HR at 1 and 2 min pre-intubation and at 5 min post-intubation were also recorded to evaluate whether there was a cardiovascular response in these patients. Subsequently, the EC50 of remifentanil for blunting the cardiovascular response to 3 options of intubation was calculated using the Dixon-Mood up- and down- sequence. Results Compared with pre-induction, all the patients in 3 groups experienced significantly lower post-inductive MAP and HR [MAP of pre- and post-induction in T, F, P groups were (87.9±10.5) mm Hg vs (71.6±9.0) mm Hg, (91.8±8.8)mm Hg vs (73.5±9.9) mm Hg, (87.2±10.2) mm Hg vs (70.9±8.6) mm Hg, HR of pre- and post-induction in T, F, P groups were (78.8±11.6) min-1 vs (68.7±8.5) min-1,(74.8±10.3) min-1 vs (64.1±6.7) min-1, (76.7±8.2) min-1 vs (67.3±8.3) min-1,1 mm Hg=0.133 kPa, P<0.05] but BIS unchanged basically (P>0.05). The EC50 of remifentail for blunting cardiovascular response to intubation was 4.47 μg/L for group T, 4.78 μg/L for group F and 2.05 μg/L for group P, respectively. Conclusion EC50 of remifentail for blunting cardiovascular responses to intubation as shown by Minto's model appears slightly higher in LMA-Fastrach than that in tracheal intubation, and the lowest is in LMA-Proseal intubation.     

Effect of neuropeptide Y on calcium/calmodulin-dependent protein kinase Ⅱ in rat cardiomyocytes

Objective To explore the effect of neuropeptide Y (NPY) on calcium/calmodulindependent protein kinase Ⅱ (CaMK Ⅱ ) in rat cardiomyocytes.Methods The cardiomyocytes from neonatal Sprague-Dawley (SD) rats were primarily cultured and divided into the control and NPY groups (n=6 each).The NPY group was added with 100 nmol/L NPY (final concentration), while the control group was left untreated.After 15 min, the activity of CaMK Ⅱ was detected by isotope 32P incorporation assay, and the expression of phospho - CaMK Ⅱ (p - CaMK Ⅱ ) protein by Western blotting.After 24 h, intranuclear concentration of Ca2+ in resting cardiomyocytes was recorded under laser scanning confocal microscope (LSCM).In addition, real-time PCR was used to detect the expressions of P-myosin heavy chain (β-MHC)mRNA and atrial natriuretic factor (ANF) mRNA in cardiomyocytes.Results After NPY stimulation for 15 min, the NPY group showed significantly elevated activity of CaMK Ⅱ (336 094.80±0 744.61 vs 273 301.50±±16 737..99, P＜0.05) and increased expression of p-CaMK Ⅱ protein in cardiomyocytes, compared with the control group.After 24 h, the NYP group showed a significant increase in intranuclear Ca2+ concentration compared wiith the control group (226.87±17.37 vs 84.04±6.50,P＜0.01).Moreover, real-time PCR also showed signficant increase in expressions of β- MHC and ANF mRNA.Conclusion The CaMK Ⅱ is activated with the increase of intranuclear Ca2+ concentration by NPY, which may play a major role in NYP-induced cardiomyocyte hypertrophy.     

Impact of CCAAT enhancer binding protein α on the differentiation and apoptosis of acute myeloid leukemia HL60 cells

Objective To investigate the effect of CCAAT enhancer binding protein α(C/EBPα) on differentiation and apoptosis in the acute myeloid leukemia HL60 cells in vitro and in vivo and its possible mechanism. Methods The C/EBPα expression plasmid pEGFP-C/EBPα and empty control plasmid were respectively transfected into HL60 cells with cationic liposome as transfected group and empty plasmid transfected group, and untreated HL60 cells served as control group. The cells stably expressing the C/EBPα gene were obtained by G418 selection. The morphological changes were observed under light microscope following WrightGiemsa staining. MTT assay was employed to evaluate cell proliferation, and flow cytometry(FCM) was performed to analyze cell apoptosis. Meanwhile, the expression of c-myc was respectively detected by RT-PCR and Western blot both at the mRNA and protein level. Twenty BALB/c nude mice were divided into 3 groups in a completely randomized design: 7 mice in transfected group, 7 mice in empty plasmid transfected group and 6 in control group. Three kinds of cells including pEGFP-C/EBPα-HL60 cells, pEGFP -HL60 cells and the control HL60 cells were injected into mice separately through the subcutaneous. The mice were sacrificed at 20 d after injection. The mass and size of subcutaneous xenograft tumors were measured and the cell apoptosis of subcutaneous tumor were detected by TUNEL. Results The pEGFP-C/EBPα-HL60 cell line stably expressing the C/EBPα gene was screened out. Compared to either empty plasmid transfected group or control group, the expression of C/EBPα could promote cellular differentiation of HL60. FCM showed higher apoptotic rate in transfected group[ (21.9±4.5)%,P＜0.05 ] ,while (5.4±1.4)% in control group and (5.0±1.3)% in empty plasmid transfected group. c-myc expression was significantly down-regulated by C/EBPα both at the mRNA and protein level. The mass and size of tumors in transfected group were smaller than those in empty plasmid transfected group and control group [ (5.35±1.12)g and(25±4)mm in control group, (5.12±1.31)g and ( 18±3)mm in empty plasmid transfected group ,while (3.26±0.72)g and ( 11±2)mm in transfected group, all P＜0.05]. More apoptosis cells were found in subcutaneous tumor of transfected group(both P＜0.05). Conclusion C/EBPα can not only inhibit the proliferation, but also induce massive apoptosis of HL60 cells, meanwhile C/EBPα is a tumor suppressor of acute myeloid leukemia.     

航天特定环境下抑郁症模型大鼠血清、海马及延髓中单胺神经递质含量变化

Objective To explore the changes of monoamine neurotransmitters in serum,hippocampus and medulla oblongata of experimental depression rats under simulated space-specific environment. Methods Thirty rats with similar behavior scores at open field test were randomized into model group and control group (n=15 each). Classical pattern of depression combined with simulated spacespecific environment was used to establish the rat models of depression in the model group, whereas the rats in the control group received no treatment. Under simulated space-specific environment, the changes of behavior were observed and the changes of neurotransmitters including 5 - hydroxytryptamine (5 - HT) ,dopamine (DA) and norepinephrine (NE) in serum, hippocampus and medulla oblongata were measured.Results Compared with controls, the depressed rats walked through fewer squares, experienced less upright actions, more grooming and time at the central square (all P＜ 0.05). In the model rats, the serum contents of 5-HT [ (334.23±110.45)μg/L vs (248.76±51.83)μg/L], DA [ (109.19±26.86) μg/L vs (88.42±12.63) μg/L] and NE [ ( 102.46±39.31 ) μg/L vs (74.88±12.04) ] were significantly elevated (all P＜0.05),and NE [ (9.99±8.02) μg/L vs (25.41±5.68)μg/L,P＜0.05] in hippocampus was reduced, as compared with controls. Conclusion The major cause of space environment-related depression may be associated with the reduced level of NE in hippocampus and not associated with the reduced levels of 5-HT and DA in serum.     

慢性乙肝患者血清趋化因子RANTES水平与肝功能生化指标等的相关性研究

Objective To investigate the level of the serum chemokine RANTES and its correlation with serum biochemical indices of liver function test, HBeAg and HBV DNA load in patients with chronic hepatitis B.Methods 144 patients with chronic hepatitis B (observed group) and 18 normal cases (control group) were enrolled in this study. The serum level of chemokine RANTES was detected with an ABC-ELISA assay. Statistical analysis was performed on the software of SPSS13.0. Results The serum chemokine RANTES level in the observed group (3930.12 ng/ml±2856.96) ng/ml was significantly higher than that in the control group (329.46 ng/ml±152.23) ng/ml. The results from the observed group indicated the positive correlation of serum RANTES level with indices of liver function test, including ALT (r=0. 197, P=0.018), AST(r=0.239, P=0.004) and TBil (r=0.316, P=0.001), but did not with PTA (r=-0.078, P=0.357). Neither difference of serum chemokine RANTES level between HBeAg-positive group and HBeAg-negative group nor that between high HBV DNA load group (≥105 copies/ml) and low HBV DNA load group (< 105 copies/ml) were statistically significant (P=0.407 and 0.185, respectively). Conclusions Serum chemokine RANTES level in patients with chronic hepatitis B elevates significantly and is not affected by HBeAg or HBV DNA load. Its positive correlation with indices of liver function test indicates that RANTES might play an important rule in the pathogenesis of chronic hepatitis B.     

肝细胞生长因子激活胶原降解途径逆转心肌纤维化

Objective To study the effects of hepatocyte growth factor (HGF) on angiotensin Ⅱ(Ang Ⅱ )-induced synthesis and degradation of cardiac fibroblast collagen in neonatal mice.Methods Cardiac fibroblasts (CFs) of neonatal Sprague-Dawley (SD) rats were isolated by differential adhesion, and were identified by immunocytochemistry.The cells were assigned to normal control group (group C) , 10-6 mol/L Ang Ⅱ group (group A), 10μg/L HGF + 10-6 mol/L Ang Ⅱ group (group H1) and 100μg/L HGF +10-6 mol/L Ang Ⅱ group (group H2).All the groups were treated for 48 h.Hydroxyproline assay was used to determine the collagen protein level.RT-PCR was used to detect the expression of ColⅠ, ColⅢ, matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of metalloproteinase-1 (TIMP-l) mRNA, and Western blotting was employed to measure Col I protein.In addition, MMP-1 activity was evaluated by collagenase Ⅰ activity assay kit.Results After intervention for 48 h, the collagen protein levels in groups A and H1 were significantly higher compared with group C [ (39.08±2.71) mg/L vs (37.45±4.22) mg/L vs (23.73 ±±1.62) mg/L, all P＜0.05] and the collagen protein level in group H2 [(26.03±3.04) mg/L] was lower than those of groups A and Hl(P＜0.05), but was not statistically different from group C.The expression levels of Col Ⅰ ,Col M and TIMP-1 showed an order of group A＞group HI＞group H2> group C (all P＜0.05), and for MMP-1 mRNA, group A ＜ group H1 ＜ group H2 ＜ group C (all P＜0.05).The levels of Col I protein expression showed an order of group A＞group HI＞group H2＞group C (89.90±4.29 vs 68.21?1.43 vs 36.08?.8 vs 30.14?.36, all P＜0.05).The expression and activity of MMP-1 mRNA in group A and H1 were obviously lower than those in group C (all P＜0.05), while group H2 were comparable to group C in these data.Conclusion HGF re-regulates MMP-1-TIMP-1 balance and ameliorates myocardiac fibrosis mainly by activating collagen degradation.     

胰岛素强化治疗在2型糖尿病骨折患者围手术期的应用

Objective To investigate the best way to control the blood sugar level during the perioperation of bone fracture patients with type 2 diabetes(T2DM).Methods Bone fracture patients with T2DM were randomly divided into three groups:continuous subcutaneous insulin infusion group(insulin aspart,group CSII,n=20),glargine treatment group(insulin aspart+insulin glargine,group GA,n=20),and NPH treatment(insulin aspart+rh-insulin,group NA,n=20).The levels of fasting plasma glucose(FPG)and the 2 hours postprandial glucose(2h PG),blood glucose fluctuation(BGF),insulin dosage(ID),good effective time(GET),incidence of hypoglycemia,dawn phenomenon and infection,average time of stitches removal(ATSR),average hospitalized length(AHL)of three groups were compared.Results FPG and 2hPG,ID in group CSII[(6.32±1.18)mmol/L,(7.72±1.53)mmol/L,(35.40±1.60)IU]and group GA [(6.25±0.88)mmol/L,(7.32±1.17)mmol/L,(36.20±0.80)IU]were significantly lower than those of group NA [(7.44±1.36)mmol/L,(8.52±0.76)mmol/L,(40.50±2.40)IU,all P<0.05],simulaneously,BGF,GET incidence of complications,ATSR,AHL of group CSII and GA were significantly lower than those of group NA(all P<0.05).There were not significant difference between group CSII and group GA.Compared with group CSII,group GA had less costs in-hospital and better practicability.Conclusion Both CSII and insulin glargine combined with insulin aspart can effectively,safely,rapidly and stablely control hyperglycemia.and might be the first choice to control blood sugar for bone fracture patients with T2DM in perioperation.     

胰岛素强化治疗在2型糖尿病骨折患者围手术期的应用

Objective To investigate the best way to control the blood sugar level during the perioperation of bone fracture patients with type 2 diabetes(T2DM).Methods Bone fracture patients with T2DM were randomly divided into three groups:continuous subcutaneous insulin infusion group(insulin aspart,group CSII,n=20),glargine treatment group(insulin aspart+insulin glargine,group GA,n=20),and NPH treatment(insulin aspart+rh-insulin,group NA,n=20).The levels of fasting plasma glucose(FPG)and the 2 hours postprandial glucose(2h PG),blood glucose fluctuation(BGF),insulin dosage(ID),good effective time(GET),incidence of hypoglycemia,dawn phenomenon and infection,average time of stitches removal(ATSR),average hospitalized length(AHL)of three groups were compared.Results FPG and 2hPG,ID in group CSII[(6.32±1.18)mmol/L,(7.72±1.53)mmol/L,(35.40±1.60)IU]and group GA [(6.25±0.88)mmol/L,(7.32±1.17)mmol/L,(36.20±0.80)IU]were significantly lower than those of group NA [(7.44±1.36)mmol/L,(8.52±0.76)mmol/L,(40.50±2.40)IU,all P<0.05],simulaneously,BGF,GET incidence of complications,ATSR,AHL of group CSII and GA were significantly lower than those of group NA(all P<0.05).There were not significant difference between group CSII and group GA.Compared with group CSII,group GA had less costs in-hospital and better practicability.Conclusion Both CSII and insulin glargine combined with insulin aspart can effectively,safely,rapidly and stablely control hyperglycemia.and might be the first choice to control blood sugar for bone fracture patients with T2DM in perioperation.     

胰岛素强化治疗在2型糖尿病骨折患者围手术期的应用

Objective To investigate the best way to control the blood sugar level during the perioperation of bone fracture patients with type 2 diabetes(T2DM).Methods Bone fracture patients with T2DM were randomly divided into three groups:continuous subcutaneous insulin infusion group(insulin aspart,group CSII,n=20),glargine treatment group(insulin aspart+insulin glargine,group GA,n=20),and NPH treatment(insulin aspart+rh-insulin,group NA,n=20).The levels of fasting plasma glucose(FPG)and the 2 hours postprandial glucose(2h PG),blood glucose fluctuation(BGF),insulin dosage(ID),good effective time(GET),incidence of hypoglycemia,dawn phenomenon and infection,average time of stitches removal(ATSR),average hospitalized length(AHL)of three groups were compared.Results FPG and 2hPG,ID in group CSII[(6.32±1.18)mmol/L,(7.72±1.53)mmol/L,(35.40±1.60)IU]and group GA [(6.25±0.88)mmol/L,(7.32±1.17)mmol/L,(36.20±0.80)IU]were significantly lower than those of group NA [(7.44±1.36)mmol/L,(8.52±0.76)mmol/L,(40.50±2.40)IU,all P<0.05],simulaneously,BGF,GET incidence of complications,ATSR,AHL of group CSII and GA were significantly lower than those of group NA(all P<0.05).There were not significant difference between group CSII and group GA.Compared with group CSII,group GA had less costs in-hospital and better practicability.Conclusion Both CSII and insulin glargine combined with insulin aspart can effectively,safely,rapidly and stablely control hyperglycemia.and might be the first choice to control blood sugar for bone fracture patients with T2DM in perioperation.     

慢性乙肝患者血清趋化因子RANTES水平与肝功能生化指标等的相关性研究

Objective To investigate the level of the serum chemokine RANTES and its correlation with serum biochemical indices of liver function test, HBeAg and HBV DNA load in patients with chronic hepatitis B.Methods 144 patients with chronic hepatitis B (observed group) and 18 normal cases (control group) were enrolled in this study. The serum level of chemokine RANTES was detected with an ABC-ELISA assay. Statistical analysis was performed on the software of SPSS13.0. Results The serum chemokine RANTES level in the observed group (3930.12 ng/ml±2856.96) ng/ml was significantly higher than that in the control group (329.46 ng/ml±152.23) ng/ml. The results from the observed group indicated the positive correlation of serum RANTES level with indices of liver function test, including ALT (r=0. 197, P=0.018), AST(r=0.239, P=0.004) and TBil (r=0.316, P=0.001), but did not with PTA (r=-0.078, P=0.357). Neither difference of serum chemokine RANTES level between HBeAg-positive group and HBeAg-negative group nor that between high HBV DNA load group (≥105 copies/ml) and low HBV DNA load group (< 105 copies/ml) were statistically significant (P=0.407 and 0.185, respectively). Conclusions Serum chemokine RANTES level in patients with chronic hepatitis B elevates significantly and is not affected by HBeAg or HBV DNA load. Its positive correlation with indices of liver function test indicates that RANTES might play an important rule in the pathogenesis of chronic hepatitis B.     

ApoB/apoA1 is an effective predictor of coronary heart disease risk in overweight and obesity

We investigated the relationship of apoB/apoA1 ratio and coronary heart disease (CHD) in persons who were overweight or obese.The subjects were divided by the body mass indexes (BMI) into the normal weight group (n=397,BMI<24 kg/m 2) and the overweight group (n=400,BMI>24 kg/m 2).Our results showed that the overweight group had higher blood pressure [(130.15±19.01) mmHg vs (123.66±18.70) mmHg] and higher levels of blood sugar [(7.09±2.89) mmol/L vs (6.21±2.59) mmol/L],triglyceride [(1.93±1.19) mmol/L vs (1.44±0.85) mmol/L],total cholesterol [(4.26±1.06) mmol/L vs (4.09±0.99) mmol/L],low-density lipoprotein cholesterol (LDL-C) [(2.56±0.75) mmol/L vs (2.39±0.72) mmol/L],and apoB [(0.83±0.27) mg/L vs (0.78±0.23) mg/L],and a higher apoB/apoA1 ratio (0.83±0.27 vs 0.75±0.25) and lower levels high-density lipoprotein cholesterol [(1.10±0.26) mmol/L vs (1.21±0.31) mmol/L] and apoA1 [(1.04±0.20) mg/L vs (1.08±0.22) mg/L] than those of the normal weight group (all P < 0.05).The prevalence of CHD in the over-weight group in the lowest LDL quartile was almost twice greater than that of the highest apoB/apoA1 quartile,compared with the subjects in the lowest apoB/apoA1 quartile.The higher apoB/apoA1 quartile was in agreement with the higher prevalence of CHD.In the overweight and obesity group,the area under ROC curve (AUC) was the highest for apoB/apoA1 (0.655).The cut-off point of apoB/apoA1 for optimal sensitivity and specificity was at 0.80,with a sensitivity of 57.19% and a specificity of 71.72%.In conclusion,apoB and apoA1 were simple clinical indicators,and the apoB/apoA1 ratio was closely related with CHD in overweight and obese patients.The apoB/apoA1 ratio may provide some useful information in the differential diagnosis.     

慢性乙肝患者血清趋化因子RANTES水平与肝功能生化指标等的相关性研究

Objective To investigate the level of the serum chemokine RANTES and its correlation with serum biochemical indices of liver function test, HBeAg and HBV DNA load in patients with chronic hepatitis B.Methods 144 patients with chronic hepatitis B (observed group) and 18 normal cases (control group) were enrolled in this study. The serum level of chemokine RANTES was detected with an ABC-ELISA assay. Statistical analysis was performed on the software of SPSS13.0. Results The serum chemokine RANTES level in the observed group (3930.12 ng/ml±2856.96) ng/ml was significantly higher than that in the control group (329.46 ng/ml±152.23) ng/ml. The results from the observed group indicated the positive correlation of serum RANTES level with indices of liver function test, including ALT (r=0. 197, P=0.018), AST(r=0.239, P=0.004) and TBil (r=0.316, P=0.001), but did not with PTA (r=-0.078, P=0.357). Neither difference of serum chemokine RANTES level between HBeAg-positive group and HBeAg-negative group nor that between high HBV DNA load group (≥105 copies/ml) and low HBV DNA load group (< 105 copies/ml) were statistically significant (P=0.407 and 0.185, respectively). Conclusions Serum chemokine RANTES level in patients with chronic hepatitis B elevates significantly and is not affected by HBeAg or HBV DNA load. Its positive correlation with indices of liver function test indicates that RANTES might play an important rule in the pathogenesis of chronic hepatitis B.     

慢性乙肝患者血清趋化因子RANTES水平与肝功能生化指标等的相关性研究

Objective To investigate the level of the serum chemokine RANTES and its correlation with serum biochemical indices of liver function test, HBeAg and HBV DNA load in patients with chronic hepatitis B.Methods 144 patients with chronic hepatitis B (observed group) and 18 normal cases (control group) were enrolled in this study. The serum level of chemokine RANTES was detected with an ABC-ELISA assay. Statistical analysis was performed on the software of SPSS13.0. Results The serum chemokine RANTES level in the observed group (3930.12 ng/ml±2856.96) ng/ml was significantly higher than that in the control group (329.46 ng/ml±152.23) ng/ml. The results from the observed group indicated the positive correlation of serum RANTES level with indices of liver function test, including ALT (r=0. 197, P=0.018), AST(r=0.239, P=0.004) and TBil (r=0.316, P=0.001), but did not with PTA (r=-0.078, P=0.357). Neither difference of serum chemokine RANTES level between HBeAg-positive group and HBeAg-negative group nor that between high HBV DNA load group (≥105 copies/ml) and low HBV DNA load group (< 105 copies/ml) were statistically significant (P=0.407 and 0.185, respectively). Conclusions Serum chemokine RANTES level in patients with chronic hepatitis B elevates significantly and is not affected by HBeAg or HBV DNA load. Its positive correlation with indices of liver function test indicates that RANTES might play an important rule in the pathogenesis of chronic hepatitis B.     

慢性乙肝患者血清趋化因子RANTES水平与肝功能生化指标等的相关性研究

Objective To investigate the level of the serum chemokine RANTES and its correlation with serum biochemical indices of liver function test, HBeAg and HBV DNA load in patients with chronic hepatitis B.Methods 144 patients with chronic hepatitis B (observed group) and 18 normal cases (control group) were enrolled in this study. The serum level of chemokine RANTES was detected with an ABC-ELISA assay. Statistical analysis was performed on the software of SPSS13.0. Results The serum chemokine RANTES level in the observed group (3930.12 ng/ml±2856.96) ng/ml was significantly higher than that in the control group (329.46 ng/ml±152.23) ng/ml. The results from the observed group indicated the positive correlation of serum RANTES level with indices of liver function test, including ALT (r=0. 197, P=0.018), AST(r=0.239, P=0.004) and TBil (r=0.316, P=0.001), but did not with PTA (r=-0.078, P=0.357). Neither difference of serum chemokine RANTES level between HBeAg-positive group and HBeAg-negative group nor that between high HBV DNA load group (≥105 copies/ml) and low HBV DNA load group (< 105 copies/ml) were statistically significant (P=0.407 and 0.185, respectively). Conclusions Serum chemokine RANTES level in patients with chronic hepatitis B elevates significantly and is not affected by HBeAg or HBV DNA load. Its positive correlation with indices of liver function test indicates that RANTES might play an important rule in the pathogenesis of chronic hepatitis B.     

慢性乙肝患者血清趋化因子RANTES水平与肝功能生化指标等的相关性研究

Objective To investigate the level of the serum chemokine RANTES and its correlation with serum biochemical indices of liver function test, HBeAg and HBV DNA load in patients with chronic hepatitis B.Methods 144 patients with chronic hepatitis B (observed group) and 18 normal cases (control group) were enrolled in this study. The serum level of chemokine RANTES was detected with an ABC-ELISA assay. Statistical analysis was performed on the software of SPSS13.0. Results The serum chemokine RANTES level in the observed group (3930.12 ng/ml±2856.96) ng/ml was significantly higher than that in the control group (329.46 ng/ml±152.23) ng/ml. The results from the observed group indicated the positive correlation of serum RANTES level with indices of liver function test, including ALT (r=0. 197, P=0.018), AST(r=0.239, P=0.004) and TBil (r=0.316, P=0.001), but did not with PTA (r=-0.078, P=0.357). Neither difference of serum chemokine RANTES level between HBeAg-positive group and HBeAg-negative group nor that between high HBV DNA load group (≥105 copies/ml) and low HBV DNA load group (< 105 copies/ml) were statistically significant (P=0.407 and 0.185, respectively). Conclusions Serum chemokine RANTES level in patients with chronic hepatitis B elevates significantly and is not affected by HBeAg or HBV DNA load. Its positive correlation with indices of liver function test indicates that RANTES might play an important rule in the pathogenesis of chronic hepatitis B.     

慢性乙肝患者血清趋化因子RANTES水平与肝功能生化指标等的相关性研究

Objective To investigate the level of the serum chemokine RANTES and its correlation with serum biochemical indices of liver function test, HBeAg and HBV DNA load in patients with chronic hepatitis B.Methods 144 patients with chronic hepatitis B (observed group) and 18 normal cases (control group) were enrolled in this study. The serum level of chemokine RANTES was detected with an ABC-ELISA assay. Statistical analysis was performed on the software of SPSS13.0. Results The serum chemokine RANTES level in the observed group (3930.12 ng/ml±2856.96) ng/ml was significantly higher than that in the control group (329.46 ng/ml±152.23) ng/ml. The results from the observed group indicated the positive correlation of serum RANTES level with indices of liver function test, including ALT (r=0. 197, P=0.018), AST(r=0.239, P=0.004) and TBil (r=0.316, P=0.001), but did not with PTA (r=-0.078, P=0.357). Neither difference of serum chemokine RANTES level between HBeAg-positive group and HBeAg-negative group nor that between high HBV DNA load group (≥105 copies/ml) and low HBV DNA load group (< 105 copies/ml) were statistically significant (P=0.407 and 0.185, respectively). Conclusions Serum chemokine RANTES level in patients with chronic hepatitis B elevates significantly and is not affected by HBeAg or HBV DNA load. Its positive correlation with indices of liver function test indicates that RANTES might play an important rule in the pathogenesis of chronic hepatitis B.